Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment
(Q46641346)
scientific article published on August 1, 1998
scientific article published on August 1, 1998
Language:
other details
description | scientific article published on August 1, 1998 |
External Links
(P356) |
10.1200/JCO.1998.16.8.2659
|
(P698) |
9704716
|
(P8608) |
release_7ygw5ufnizccdimhdummul545u
|